CO5271712A1 - CHEMICAL AND INTERMEDIARY PROCESSES - Google Patents
CHEMICAL AND INTERMEDIARY PROCESSESInfo
- Publication number
- CO5271712A1 CO5271712A1 CO00090190A CO00090190A CO5271712A1 CO 5271712 A1 CO5271712 A1 CO 5271712A1 CO 00090190 A CO00090190 A CO 00090190A CO 00090190 A CO00090190 A CO 00090190A CO 5271712 A1 CO5271712 A1 CO 5271712A1
- Authority
- CO
- Colombia
- Prior art keywords
- group
- primary
- ch2ch
- formation
- chemical
- Prior art date
Links
- -1 phosphoryl group Chemical group 0.000 abstract 4
- 230000015572 biosynthetic process Effects 0.000 abstract 3
- 150000000180 1,2-diols Chemical class 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
Un proceso para la formación de un grupo primario mono-fosforilo (OPO(OH)2) en una funcionalidad terminal 1,2-diol-propanoil (HO-CH2CH(OH)-CO-) que comprende los pasos de: (i) formación de una especie protegida primaria 1,2-diol (PgO-CH2CH(OH)-CO-);(ii) formación de un grupo fosforilo secundario (opcionalmente protegido) y (iii) tratamiento de este grupo fosforilo secundario con ácido para desproteger la función de alcohol protegido primario y volver a arreglar el grupo fosforilo secundario a un grupo fosforilo primario (para dar una (HO)2OPO-CH2CH(OH)-CO-fundionalidad); donde Pg es un grupo de protección.A process for the formation of a mono-phosphoryl (OPO (OH) 2) primary group in a 1,2-diol-propanoyl (HO-CH2CH (OH) -CO-) terminal functionality comprising the steps of: (i) formation of a primary protected species 1,2-diol (PgO-CH2CH (OH) -CO -); (ii) formation of a secondary phosphoryl group (optionally protected) and (iii) treatment of this secondary phosphoryl group with acid to deprotect the function of primary protected alcohol and rearrange the secondary phosphoryl group to a primary phosphoryl group (to give a (HO) 2OPO-CH2CH (OH) -CO-foundry); where Pg is a protection group.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9928499.4A GB9928499D0 (en) | 1999-12-03 | 1999-12-03 | Chemical processes and intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5271712A1 true CO5271712A1 (en) | 2003-04-30 |
Family
ID=10865576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO00090190A CO5271712A1 (en) | 1999-12-03 | 2000-11-24 | CHEMICAL AND INTERMEDIARY PROCESSES |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1237895A2 (en) |
JP (1) | JP2003515539A (en) |
KR (1) | KR20020058072A (en) |
CN (1) | CN1433421A (en) |
AR (1) | AR026700A1 (en) |
AU (1) | AU762241B2 (en) |
BG (1) | BG106728A (en) |
BR (1) | BR0016087A (en) |
CA (1) | CA2395052A1 (en) |
CO (1) | CO5271712A1 (en) |
CZ (1) | CZ20021912A3 (en) |
EE (1) | EE200200282A (en) |
GB (1) | GB9928499D0 (en) |
HU (1) | HUP0204052A2 (en) |
IL (1) | IL149641A0 (en) |
IS (1) | IS6401A (en) |
MX (1) | MXPA02005396A (en) |
NO (1) | NO20022605L (en) |
PL (1) | PL364762A1 (en) |
SK (1) | SK7862002A3 (en) |
WO (1) | WO2001040236A2 (en) |
ZA (1) | ZA200203876B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0113297D0 (en) * | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
EP1427711B1 (en) | 2001-09-11 | 2005-07-13 | AstraZeneca AB | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
AR038536A1 (en) | 2002-02-25 | 2005-01-19 | Upjohn Co | N-ARIL-2-OXAZOLIDINONA-5- CARBOXAMIDS AND ITS DERIVATIVES |
US7141588B2 (en) | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
US7473699B2 (en) | 2002-02-28 | 2009-01-06 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents |
EP1480975A2 (en) | 2002-02-28 | 2004-12-01 | Astrazeneca AB | Chemical compounds |
US7094900B2 (en) | 2002-08-12 | 2006-08-22 | Pharmacia & Upjohn Company Llc | N-Aryl-2-oxazolidinones and their derivatives |
TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
EP1565186B1 (en) | 2002-11-21 | 2006-11-02 | Pharmacia & Upjohn Company LLC | N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents |
US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
EP2492264A3 (en) | 2003-06-03 | 2012-12-19 | Rib-X Pharmaceuticals, Inc. | Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
US7304050B2 (en) | 2003-09-16 | 2007-12-04 | Pfizer Inc. | Antibacterial agents |
TW200526649A (en) | 2003-12-17 | 2005-08-16 | Rib X Pharmaceuticals Inc | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
JP5383037B2 (en) | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | Macrocyclic compounds and methods of making and using them |
JP5534497B2 (en) | 2005-06-08 | 2014-07-02 | メリンタ セラピューティクス,インコーポレイテッド | Method for synthesizing triazoles |
CA2664572C (en) | 2006-09-25 | 2015-06-16 | Wockhardt Research Centre | Substituted piperidinophenyl oxazolidinones |
WO2014014845A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311787A (en) * | 1998-06-05 | 2001-09-05 | 阿斯特拉曾尼卡有限公司 | Oxazolidinone derivatives, process for their prepn. and pharmaceutical compositions contg. same |
-
1999
- 1999-12-03 GB GBGB9928499.4A patent/GB9928499D0/en not_active Ceased
-
2000
- 2000-11-24 CO CO00090190A patent/CO5271712A1/en not_active Application Discontinuation
- 2000-11-28 WO PCT/GB2000/004527 patent/WO2001040236A2/en not_active Application Discontinuation
- 2000-11-28 AU AU17156/01A patent/AU762241B2/en not_active Ceased
- 2000-11-28 SK SK786-2002A patent/SK7862002A3/en unknown
- 2000-11-28 CZ CZ20021912A patent/CZ20021912A3/en unknown
- 2000-11-28 JP JP2001540991A patent/JP2003515539A/en active Pending
- 2000-11-28 PL PL00364762A patent/PL364762A1/en unknown
- 2000-11-28 HU HU0204052A patent/HUP0204052A2/en unknown
- 2000-11-28 KR KR1020027007072A patent/KR20020058072A/en not_active Application Discontinuation
- 2000-11-28 IL IL14964100A patent/IL149641A0/en unknown
- 2000-11-28 CN CN00818735A patent/CN1433421A/en active Pending
- 2000-11-28 MX MXPA02005396A patent/MXPA02005396A/en unknown
- 2000-11-28 EP EP00979764A patent/EP1237895A2/en not_active Withdrawn
- 2000-11-28 BR BR0016087-3A patent/BR0016087A/en not_active Application Discontinuation
- 2000-11-28 CA CA002395052A patent/CA2395052A1/en not_active Abandoned
- 2000-11-28 EE EEP200200282A patent/EE200200282A/en unknown
- 2000-12-01 AR ARP000106370A patent/AR026700A1/en unknown
-
2002
- 2002-05-15 ZA ZA200203876A patent/ZA200203876B/en unknown
- 2002-05-20 BG BG106728A patent/BG106728A/en unknown
- 2002-05-28 IS IS6401A patent/IS6401A/en unknown
- 2002-05-31 NO NO20022605A patent/NO20022605L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001040236A2 (en) | 2001-06-07 |
IL149641A0 (en) | 2002-11-10 |
CZ20021912A3 (en) | 2002-08-14 |
WO2001040236A3 (en) | 2002-05-10 |
NO20022605L (en) | 2002-06-26 |
JP2003515539A (en) | 2003-05-07 |
BR0016087A (en) | 2002-08-06 |
AU762241B2 (en) | 2003-06-19 |
BG106728A (en) | 2003-02-28 |
EE200200282A (en) | 2003-06-16 |
CN1433421A (en) | 2003-07-30 |
EP1237895A2 (en) | 2002-09-11 |
MXPA02005396A (en) | 2002-11-29 |
ZA200203876B (en) | 2003-08-15 |
NO20022605D0 (en) | 2002-05-31 |
SK7862002A3 (en) | 2003-02-04 |
KR20020058072A (en) | 2002-07-12 |
IS6401A (en) | 2002-05-28 |
AU1715601A (en) | 2001-06-12 |
HUP0204052A2 (en) | 2003-03-28 |
CA2395052A1 (en) | 2001-06-07 |
AR026700A1 (en) | 2003-02-26 |
GB9928499D0 (en) | 2000-02-02 |
PL364762A1 (en) | 2004-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5271712A1 (en) | CHEMICAL AND INTERMEDIARY PROCESSES | |
AR004122A1 (en) | PROCEDURE FOR THE PREPARATION OF A COMPOUND OF DIHALOAZOLOPIRIMIDINES AND A PROCEDURE FOR THE PREPARATION OF AN INTERMEDIARY OF SUCH PROCEDURE | |
KR970704353A (en) | STRONGLY ACIDIC STERILE WATER CONTAINING LOW-CONDENTRATION HYPOCHLOROUS ACID, METHOD OF FORMING STRONGLY ACIDIC STERILE WATER CONTAINING LOW-CONCENTRATION HYPOCHLOROUS AC | |
ES2170147T3 (en) | METHOD FOR IMPROVING THE EFFECTIVENESS OF AGRICULTURAL CHEMICALS. | |
PT1296948E (en) | The invention relates to a process for the preparation of a medicament for the preparation of medicaments for treating premature ejaculation. | |
DE69504184D1 (en) | NEW CATIONIC PHOSPHOLIPIDS FOR TRANSFECTION | |
DE69825931D1 (en) | Process for the production of SOI substrates with a very efficient removal of damage caused by ion implantation | |
BRPI0116397B8 (en) | compound, process for preparing the same, use of a compound, method for producing an ibat inhibiting effect in a warm-blooded animal, and pharmaceutical composition | |
SG133542A1 (en) | Formulation for removal of photoresist, etch residue and barc | |
BR0114576A (en) | Compound, pharmaceutical composition, use of a compound, method of treating a disease state and process for preparing a compound | |
AR027106A1 (en) | WATER TREATMENT METHOD AND APPLIANCE | |
ES2180628T3 (en) | PROCESS TO PREPARE COPPER PIRITION. | |
ES2170813T3 (en) | 2,2-DICHLOROALCANOCARBOXILIC ACIDS, PROCESS FOR THEIR PREPARATION, MEDICINES CONTAINING THEM AND THEIR USE TO TREAT INSULIN RESISTANCE. | |
ES2082735T3 (en) | PRODUCT FOR HAIR TREATMENT AND PROCEDURE FOR USE. | |
ES2116954T1 (en) | DERIVATIVES OF ACTIVE SUBSTANCE DISSOCIABLE THROUGH HYDROLYSIS, PRODUCTS FOR THE TREATMENT OF HAIR THAT CONTAIN THEM. | |
AR019123A1 (en) | PROCEDURE FOR THE PREPARATION OF (S, S) -BENCIL-2,8-DIAZABICICLO [4.3.0] NONANO | |
CO4480019A1 (en) | LIPOSOMAS OF CETOPROFEN | |
DE60103145D1 (en) | METHOD FOR PRODUCING PHOSHPHOROTHIOATE TRIESTERE | |
ES2096973T3 (en) | PHOSPHAZENE CONTAINING ORGANIC RADICALS OF SILICON, PROCESS FOR ITS PREPARATION, AND ITS USE. | |
DE69704762D1 (en) | AGENT FOR REMOVING PAINT | |
DE60126425D1 (en) | IMPROVED PROCESS FOR THE PREPARATION OF WATER-SOLUBLE O-PHOSPHONO OXYMETHYL PRODRUGS | |
DE69800801D1 (en) | METHOD FOR PRODUCING A HIGH-PURITY HYDROGEN PEROXIDE SOLUTION BY MEANS OF ION EXCHANGE IN THE PRESENCE OF ACETATIONS | |
ES2187184T3 (en) | PHOSFOEPOXIDES, MANUFACTURING PROCEDURE AND APPLICATIONS. | |
BR0112122A (en) | Ruthenium compound (ii), use of a compound, pharmaceutical composition, method for treating and / or preventing cancer, and process for preparing a compound | |
DE69403087D1 (en) | METHOD FOR PRODUCING 9- (2-HYDROXY) -ETHOXY-GUANINE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |